Sub-Micromolar Inhibition Of Sars-Cov-2 3clpro By Natural Compounds

PHARMACEUTICALS(2021)

引用 15|浏览13
暂无评分
摘要
Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (K-i = 0.81 mu M). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (K-i = 4.1 mu M), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.
更多
查看译文
关键词
SARS-CoV-2, main protease, eugenol, drug selection, enzyme inhibitors, antivirals, spectroscopy, molecular modeling
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要